BridgeMD
New treatment option for GIT Function
Official title Dexamethasone, Dexmedetomidine and Their Combination on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07329933
What this study is testing
What is Dexamethasone?
Dexamethasone is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for git function.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn the effect of Dexamethasone and Dexmedetomidine and Their Combination on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy What medical problems do participants have when taking Dexamethasone and Dexmedetomidine?
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- . Age 18-65 years.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Scheduled for elective laparoscopic cholecystectomy surgery under general anesthesia.
- Ability to provide written informed consent
You likely can't join if
- Known allergy or contraindication to any study drug (dexamethasone, dexmedetomidine, or placebo).
- Pre-existing gastrointestinal motility disorders (e.g., gastroparesis, inflammatory bowel disease).
- Chronic use of opioids, steroids, or antiemetics.
- History of severe cardiac disease (e.g., high-grade AV block, severe bradycardia).
- Uncontrolled diabetes mellitus (HbA1c \> 8.0%).
- Emergency surgery or conversion to open surgery.
See the full eligibility criteria
- . Age 18-65 years.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Scheduled for elective laparoscopic cholecystectomy surgery under general anesthesia.
- Ability to provide written informed consent
- Known allergy or contraindication to any study drug (dexamethasone, dexmedetomidine, or placebo).
- Pre-existing gastrointestinal motility disorders (e.g., gastroparesis, inflammatory bowel disease).
- Chronic use of opioids, steroids, or antiemetics.
- History of severe cardiac disease (e.g., high-grade AV block, severe bradycardia).
- Uncontrolled diabetes mellitus (HbA1c \> 8.0%).
- Emergency surgery or conversion to open surgery.
- Pregnancy or breastfeeding.
- Morbid obesity (BMI \>40).
- Severe hepatic or renal dysfunction.
The study team makes the final eligibility decision.
Where it's taking place
- Banhā, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Banhā, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.